MedPath

Assessing the intake of nutritional beverages in older adults living in residential care facilities.

Not Applicable
Completed
Conditions
Malnourished
At risk of malnutrition
Diet and Nutrition - Other diet and nutrition disorders
Registration Number
ACTRN12622000842763
Lead Sponsor
Fonterra Research and Development Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

>65 year
Male and female
Identified as malnourished or at risk of malnutrition
Prescribed nutritional supplements
Able to provide informed consent
Living in a residential care facility

Exclusion Criteria

<65 years
Cannot provide informed consent
Renal status would contraindicate the consumption of the supplement
Have a terminal illness requiring palliative care
Have a dairy or soy allergy
Require Halal or Kosher diets
Require nasogastric or parental feeding
Recent hospitalisation
Are taking dietary supplements which could influence the outcome of the study
Have a clinical condition that, in the investigator’s judgement, is contraindicated

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Compliance to nutritional beverage as assessed by weighing the amount of the beverage pre- and post-consumption, using a set of digital scales, and calculating the difference. This will be done by the researcher. The participants will be given up to two hours to consume their beverage.[ Twice daily for seven days after the start of the intervention]
Secondary Outcome Measures
NameTimeMethod
Tolerance - documentation of gastric-related adverse events via a tick box questionnaire filled out by the nursing/care staff,.<br>[ Daily throughout the intervention period];Palatability - assessed through a standardised questionnaire designed and used previously by the sponsor.[ Bi-weekly throughout the intervention period];Satiety - assessed through a standardised questionnaire designed and used previously by the sponsor.[ Bi-weekly throughout intervention period]
© Copyright 2025. All Rights Reserved by MedPath